- Entry
- $4.74
- Final
- $3.21 -32.3%
- Target
- —
- Score
- -1.00
Today, Sana biotechnology announced a historic milestone. The insulin producing islets they engineered to survive in humans without potentially fatal immunosuppression drugs have now been observed to avoid rejection for 1 year and still produce insulin. A type 1 diabetes cure is on the horizon and Sana seems to be on pace to be first to market by several years. They presented at the JP Morgan 2026 healthcare conference. You can view their presentation here: [https://ir.sana.com/node/9796/html](https://ir.sana.com/node/9796/html) Picture of the most …
— ORIGINAL POST ·
$SANA reports 1 year survival of transplanted insulin producing islets without immunosuppression
· r/wallstreetbets
· Jan 14, 2026